ATE461927T1 - Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon - Google Patents

Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon

Info

Publication number
ATE461927T1
ATE461927T1 AT07733519T AT07733519T ATE461927T1 AT E461927 T1 ATE461927 T1 AT E461927T1 AT 07733519 T AT07733519 T AT 07733519T AT 07733519 T AT07733519 T AT 07733519T AT E461927 T1 ATE461927 T1 AT E461927T1
Authority
AT
Austria
Prior art keywords
short
salts
term action
polymorphous forms
benzodiazepine
Prior art date
Application number
AT07733519T
Other languages
German (de)
English (en)
Inventor
Gary Tilbrook
Louisa Quegan
Original Assignee
Paion Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paion Uk Ltd filed Critical Paion Uk Ltd
Application granted granted Critical
Publication of ATE461927T1 publication Critical patent/ATE461927T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07733519T 2006-07-10 2007-07-10 Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon ATE461927T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0613693.1A GB0613693D0 (en) 2006-07-10 2006-07-10 Benzodiazepine salts (3)
PCT/GB2007/002583 WO2008007081A1 (en) 2006-07-10 2007-07-10 Short-acting benzodiazepine salts and their polymorphic forms

Publications (1)

Publication Number Publication Date
ATE461927T1 true ATE461927T1 (de) 2010-04-15

Family

ID=36926778

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07733519T ATE461927T1 (de) 2006-07-10 2007-07-10 Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon

Country Status (9)

Country Link
US (1) US8642588B2 (enExample)
EP (1) EP2089378B1 (enExample)
JP (1) JP5394238B2 (enExample)
AT (1) ATE461927T1 (enExample)
CA (1) CA2657369C (enExample)
DE (1) DE602007005515D1 (enExample)
ES (1) ES2343444T3 (enExample)
GB (1) GB0613693D0 (enExample)
WO (1) WO2008007081A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170091770A (ko) 2006-07-10 2017-08-09 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
EP2305647A1 (en) 2009-09-18 2011-04-06 PAION UK Limited Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepine-4-yl] propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
CN102964349A (zh) * 2011-08-31 2013-03-13 江苏恒瑞医药股份有限公司 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途
CN104968348B (zh) 2012-05-22 2018-04-17 Paion英国有限公司 包含短效苯二氮杂*类化合物的组合物
DK2891494T3 (da) 2012-08-31 2023-10-23 Paion Uk Ltd Fremgangsmåde til administration af hypnotisserende/beroligende midler
AR094963A1 (es) * 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN103202815B (zh) * 2013-05-05 2014-09-24 李友香 治疗精神疾病的注射剂
CN103232454A (zh) * 2013-05-05 2013-08-07 王元青 治疗精神疾病的药物
CN104146970A (zh) * 2013-05-05 2014-11-19 王元青 治疗精神疾病的冻干粉针剂
CN103230595B (zh) * 2013-05-05 2014-10-08 李友香 治疗精神疾病的组合物
CN106632342B (zh) * 2015-08-07 2019-01-25 成都倍特药业有限公司 苯并二氮杂*衍生物的2-萘磺酸盐及晶型和它们的制备方法
WO2017178663A1 (en) 2016-04-14 2017-10-19 Paion Uk Limited Orally inhaled and nasal benzodiazepines
CN108503644B (zh) * 2016-12-09 2019-06-14 成都倍特药业有限公司 一种苯并二氮杂*衍生物的氢溴酸盐及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933794A (en) * 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4724237A (en) 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
US5019583A (en) * 1989-02-15 1991-05-28 Glaxo Inc. N-phenyl-N-(4-piperidinyl)amides useful as analgesics
AU678503B2 (en) * 1993-09-24 1997-05-29 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
CA2143246C (en) * 1994-03-16 2000-08-22 Thierry Godel Imidazodiazepines
US5834464A (en) * 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
WO1996020941A1 (de) 1995-01-06 1996-07-11 F. Hoffmann-La Roche Ag Hydroxymethyl-imidazodiazepine und deren ester
AU4382896A (en) 1995-02-02 1996-08-21 F. Hoffmann-La Roche Ag Acetylimidazobenzodiazepines
GB9911152D0 (en) 1999-05-14 1999-07-14 Glaxo Group Ltd Short-acting benzodiazepines
US7160880B1 (en) * 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
KR20170091770A (ko) 2006-07-10 2017-08-09 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태

Also Published As

Publication number Publication date
US20100075955A1 (en) 2010-03-25
JP5394238B2 (ja) 2014-01-22
CA2657369C (en) 2014-12-09
ES2343444T3 (es) 2010-07-30
EP2089378A1 (en) 2009-08-19
JP2009542787A (ja) 2009-12-03
DE602007005515D1 (de) 2010-05-06
CA2657369A1 (en) 2008-01-17
EP2089378B1 (en) 2010-03-24
GB0613693D0 (en) 2006-08-16
US8642588B2 (en) 2014-02-04
WO2008007081A1 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
ATE480532T1 (de) Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
ATE461927T1 (de) Benzodiazepinsalze mit kurzzeitwirkung und polymorphe formen davon
ME01532B (me) Jedinjenja
ECSP088906A (es) PIRAZOLO 1,5-a PIRIMIDINAS
ECSP109964A (es) Pirimidinas bicíclicas fusionadas
CL2013000077A1 (es) Uso de compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina para tratar infecciones por paramyxoviridae; compuestos derivados de ribosas 1’ sustituidas que comprenden nucleobases de pirrolo[1,2-f][1,2,4]triazina; y composicion farmaceutica que los comprende.
CR20110314A (es) Compuestos orgánicos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CL2010001348A1 (es) Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad.
MX2009010728A (es) Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora.
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
ECSP099044A (es) Compuestos de pirimido fusionados
EA201070395A1 (ru) Ингибиторы polo-подобных киназ
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
EA201101186A1 (ru) Конденсированные пиримидины
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
MX2009005358A (es) Derivados de 5-sulfanilmetil-pirazolo[1,5-a]pirimidin-7-ol como antagonistas de cxcr2.
ECSP099806A (es) Oxazolidinonas sustituidas y su uso
ECSP088925A (es) Nitrilos espirocíclicos como inhibidores de proteasa
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
BR112012012618A2 (pt) processo para preparação de metil {4, 6-diamino-2-[1-(2-fluorobenzil) - 1h-pirazolo [3, 4-b] piridin-3-il] pirimidin-5-il} carbamato e sua purificação para uso com substância ativa farmacêutica
CL2008003472A1 (es) Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias.
EA201100303A1 (ru) Производные пиразоло[5,1-b]оксазола в качестве антагонистов cfr1
EA200901034A1 (ru) 6-БЕНЗИЛ-2,3,4,7-ТЕТРАГИДРОИНДОЛО [2,3-c]ХИНОЛИНЫ, ПРИМЕНИМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФДЭ5 (ФОСФОДИЭСТЕРАЗЫ 5)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2089378

Country of ref document: EP